Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004701 |
---|---|
Receipt number | R000005596 |
Scientific Title | A randomized phase II trial of adjuvant therapy with S-1 plus Hotyu-ekki-to (TJ41) versus S-1 alone for stage II/III gastric cancer |
Date of disclosure of the study information | 2011/02/01 |
Last modified on | 2019/04/20 21:46:14 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/12/10 11:15:34 | ||
2 | Update | 2010/12/11 06:10:52 | Public title Acronym |
|
3 | Update | 2010/12/11 13:21:39 | Narrative objectives1 Primary outcomes |
|
4 | Update | 2010/12/11 13:27:41 | Interventions/Control_1 Interventions/Control_2 Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
5 | Update | 2011/01/07 10:07:06 | UMIN ID1 |
|
6 | Update | 2011/03/18 15:09:10 | Recruitment status Anticipated trial start date |
|
7 | Update | 2011/03/23 13:15:32 | Key inclusion criteria Key inclusion criteria |
|
8 | Update | 2012/06/11 20:16:59 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
9 | Update | 2013/12/10 19:44:12 | Recruitment status |
|
10 | Update | 2014/12/10 10:04:10 | TEL |
|
11 | Update | 2019/04/20 21:34:18 | Recruitment status Date of IRB Last follow-up date |
|
12 | Update | 2019/04/20 21:41:47 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
13 | Update | 2019/04/20 21:46:14 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |